Article info
PDFPancreas
Original article
mAb Das-1 is specific for high-risk and malignant intraductal papillary mucinous neoplasm (IPMN)
- Correspondence to Mari Mino-Kenudson, Department of Pathology, Massachusetts General Hospital, 55 Fruit Street, Warren 122, Boston, MA 02114, USA; mminokenudson{at}partners.org Koushik K Das, Division of Gastroenterology, Department of Medicine, University of Pennsylvania, 1 Convention Ave, 9 Penn Tower, Philadelphia, PA 19104, USA; koushik.das{at}uphs.upenn.edu.
Citation
mAb Das-1 is specific for high-risk and malignant intraductal papillary mucinous neoplasm (IPMN)
Publication history
- Received October 7, 2013
- Revised November 1, 2013
- Accepted November 4, 2013
- First published November 25, 2013.
Online issue publication
October 26, 2017
Article Versions
- Previous version (26 October 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions